Not all adverse drug reactions originate from active component: coloring agent-induced skin eruption in a patient treated with rifampicin.
D000328:Adult; D004396:Coloring Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis*; D005079:Excipients / Q000009:adverse effects*; D006801:Humans; D008297:Male; D012293:Rifampin / Q000008:administration & dosage*; D012394:Rosaniline Dyes / Q000009:adverse effects*
D004396:Coloring Agents; D005079:Excipients; D012394:Rosaniline Dyes; C008769:sulfan blue; D012293:Rifampin